BNP Paribas Financial Markets grew its holdings in AMETEK, Inc. (NYSE:AME – Free Report) by 23.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 355,828 shares of the technology company’s stock after purchasing an additional 67,025 shares during the period. BNP Paribas Financial Markets owned about 0.15% of AMETEK worth $61,099,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in AME. Czech National Bank increased its holdings in AMETEK by 8.6% in the second quarter. Czech National Bank now owns 44,108 shares of the technology company’s stock worth $7,353,000 after buying an additional 3,499 shares during the last quarter. CWM LLC increased its holdings in AMETEK by 53.9% in the second quarter. CWM LLC now owns 10,594 shares of the technology company’s stock worth $1,766,000 after buying an additional 3,711 shares during the last quarter. Swedbank AB acquired a new position in AMETEK in the first quarter worth approximately $3,833,000. Cetera Investment Advisers increased its holdings in AMETEK by 573.2% in the first quarter. Cetera Investment Advisers now owns 59,754 shares of the technology company’s stock worth $10,929,000 after buying an additional 50,878 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its holdings in AMETEK by 68.2% in the second quarter. Assenagon Asset Management S.A. now owns 152,132 shares of the technology company’s stock worth $25,362,000 after buying an additional 61,677 shares during the last quarter. Institutional investors and hedge funds own 87.43% of the company’s stock.
AMETEK Stock Down 1.0 %
AME opened at $195.13 on Thursday. AMETEK, Inc. has a 1-year low of $149.03 and a 1-year high of $198.33. The company has a current ratio of 1.39, a quick ratio of 0.84 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $45.14 billion, a price-to-earnings ratio of 33.99, a P/E/G ratio of 3.22 and a beta of 1.16. The business has a 50 day moving average of $178.12 and a 200-day moving average of $171.26.
AMETEK Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be given a $0.28 dividend. The ex-dividend date of this dividend is Friday, December 6th. This represents a $1.12 annualized dividend and a yield of 0.57%. AMETEK’s dividend payout ratio (DPR) is currently 19.51%.
Insider Buying and Selling
In related news, Director Steven W. Kohlhagen sold 1,460 shares of the firm’s stock in a transaction on Wednesday, September 25th. The stock was sold at an average price of $171.59, for a total value of $250,521.40. Following the completion of the transaction, the director now directly owns 23,349 shares of the company’s stock, valued at $4,006,454.91. This trade represents a 5.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider David F. Hermance sold 6,243 shares of the stock in a transaction on Friday, November 8th. The stock was sold at an average price of $190.99, for a total value of $1,192,350.57. Following the transaction, the insider now owns 36,731 shares of the company’s stock, valued at $7,015,253.69. This represents a 14.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,660 shares of company stock valued at $5,958,141 over the last ninety days. 0.61% of the stock is owned by company insiders.
Analyst Ratings Changes
A number of equities analysts recently commented on the company. Mizuho increased their price objective on AMETEK from $190.00 to $200.00 and gave the stock an “outperform” rating in a report on Friday, November 1st. KeyCorp increased their price objective on AMETEK from $205.00 to $215.00 and gave the stock an “overweight” rating in a report on Friday, November 22nd. Wolfe Research raised AMETEK to a “hold” rating in a research report on Wednesday, September 18th. Redburn Atlantic raised AMETEK to a “strong-buy” rating in a research report on Friday, August 2nd. Finally, TD Cowen cut AMETEK from a “hold” rating to a “sell” rating in a research report on Monday, October 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $199.29.
View Our Latest Stock Analysis on AME
AMETEK Company Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Recommended Stories
- Five stocks we like better than AMETEK
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Profitably Trade Stocks at 52-Week Highs
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Most active stocks: Dollar volume vs share volume
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.